Literature DB >> 28843491

Recognition and management of common, rare, and novel serum protein electrophoresis and immunofixation interferences.

Christopher R McCudden1, Joannes F M Jacobs2, David Keren3, Hélène Caillon4, Thomas Dejoie4, Kristian Andersen5.   

Abstract

Protein electrophoresis and immunofixation are subject to a variety of analytical interferences that may affect monoclonal protein diagnostics performed in the context of monoclonal gammopathies. Interferences include endogenous substances, such as hemoglobin and fibrinogen, and exogenous compounds, such as radiocontrast dyes, antibiotics, and monoclonal antibody therapies. General approaches to managing interferences begin with recognition of the problem. Provided herein are examples of common, rare, and novel interferences with the goal of providing a comprehensive overview. With each example, specific methods and strategies are provided to manage analytical interferences to ensure that interpretative reports are accurate. Longstanding and newer technologies are also described to contextualize where interferences may be identified and avoided.
Copyright © 2017 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antibiotics; Contrast dye; Fibrinogen; Hemolysis; IgG4; Interferences; Monoclonal therapy; Serum protein electrophoresis

Mesh:

Substances:

Year:  2017        PMID: 28843491     DOI: 10.1016/j.clinbiochem.2017.08.013

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  7 in total

1.  Distinguishing Drug from Disease by Use of the Hydrashift 2/4 Daratumumab Assay.

Authors:  Katie L Thoren; Matthew J Pianko; Youssef Maakaroun; C Ola Landgren; Lakshmi V Ramanathan
Journal:  J Appl Lab Med       Date:  2018-05-31

2.  MALDI-TOF mass spectrometry distinguishes daratumumab from M-proteins.

Authors:  Lauren M Moore; Sun Cho; Katie L Thoren
Journal:  Clin Chim Acta       Date:  2019-02-18       Impact factor: 3.786

3.  Using MALDI-TOF mass spectrometry in peripheral blood for the follow up of newly diagnosed multiple myeloma patients treated with daratumumab-based combination therapy.

Authors:  Marion Eveillard; Neha Korde; Amanda Ciardiello; Benjamin Diamond; Alexander Lesokhin; Sham Mailankody; Eric Smith; Hani Hassoun; Malin Hultcrantz; Urvi Shah; Sydney Lu; Meghan Salcedo; Kelly Werner; Jenna Rispoli; Donna Mastey; Ola Landgren; Katie Thoren
Journal:  Clin Chim Acta       Date:  2021-02-02       Impact factor: 3.786

Review 4.  IgG4-related disease: what a hematologist needs to know.

Authors:  Luke Y C Chen; Andre Mattman; Michael A Seidman; Mollie N Carruthers
Journal:  Haematologica       Date:  2019-01-31       Impact factor: 9.941

5.  Dual detection high-speed capillary electrophoresis for simultaneous serum protein analysis and immunoassays.

Authors:  Prabhavie M Opallage; Miyuru De Silva; Robert C Dunn
Journal:  Sci Rep       Date:  2022-02-04       Impact factor: 4.379

6.  Development and validation of a deep learning-based protein electrophoresis classification algorithm.

Authors:  Nuri Lee; Seri Jeong; Kibum Jeon; Wonkeun Song; Min-Jeong Park
Journal:  PLoS One       Date:  2022-08-24       Impact factor: 3.752

7.  Simple thrombin-based method for eliminating fibrinogen interference in serum protein electrophoresis of haemodialysed patients.

Authors:  Anamarija Rade; Anamarija Đuras; Irena Kocijan; Patricija Banković Radovanović; Ana Turčić
Journal:  Biochem Med (Zagreb)       Date:  2020-04-15       Impact factor: 2.313

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.